Ha Tay Pharmaceutical JSC (HNX:DHT)

Vietnam · Delayed Price · Currency is VND

50,200

-2,800 (-5.28%)

At close: Oct 9, 2026

Market Cap	5.00T -27.7%
Revenue (ttm)	2.48T +14.8%
Net Income	40.16B -44.9%
EPS	403.09 -44.9%
Shares Out	99.63M
PE Ratio	124.54
Forward PE	n/a
Dividend	826.45 (1.65%)
Ex-Dividend Date	n/a

Volume	5,600
Open	53,000
Previous Close	53,000
Day's Range	48,200 - 53,000
52-Week Range	46,818 - 78,909
Beta	0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 29, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, pharmaceutical chemicals, and cosmetics and medical equipment primarily in Vietnam. The company provides medical material, medicinal food, and hygiene products. It also engages in the real estate; and land use rights owned, used, or leased businesses. In addition, the company produces and sells functional food products; and engages in wholesale of food products, as well as contract manufacturing services for pharmaceutical and functional food products. The compan... [Read more]

Industry Pharmaceutical Preparations

Founded 1965

Employees 586

Stock Exchange Hanoi Stock Exchange

Ticker Symbol DHT

Full Company Profile

Financial Performance

In 2025, Ha Tay Pharmaceutical JSC's revenue was 2.40 trillion, an increase of 15.13% compared to the previous year's 2.09 trillion. Earnings were 53.66 billion, a decrease of -25.24%.

Financial Statements